Changes in ventricular remodelling and clinical status during the year following a single administration of stromal cell-derived factor-1 non-viral gene therapy in chronic ischaemic heart failure patients: the STOP-HF randomized Phase II trial-Reference-Cited by-同舟云学术

Changes in ventricular remodelling and clinical status during the year following a single administration of stromal cell-derived factor-1 non-viral gene therapy in chronic ischaemic heart failure patients: the STOP-HF randomized Phase II trial

Published:2015-06-07 Issue:33 Volume:36 Page:2228-2238
ISSN:0195-668X
Container-title:European Heart Journal
language:en
Short-container-title:Eur Heart J

Author:

Chung Eugene S.,Miller Leslie,Patel Amit N.,Anderson Russell David,Mendelsohn Farrell O.,Traverse Jay,Silver Kevin H.,Shin Julia,Ewald Gregory,Farr Mary Jane,Anwaruddin Saif,Plat Francis,Fisher Scott J.,AuWerter Alexander T.,Pastore Joseph M.,Aras Rahul,Penn Marc S.

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine

Link

http://academic.oup.com/eurheartj/article-pdf/36/33/2228/7469200/ehv254.pdf

Reference33 articles.

1. Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy

2. Mechanical and Electrical Effects of Cell-Based Gene Therapy for Ischemic Cardiomyopathy Are Independent

3. SDF-1 Recruits Cardiac Stem Cell-Like Cells that Depolarize In Vivo

4. Stromal Cell–Derived Factor-1 Effects on Ex Vivo Expanded Endothelial Progenitor Cell Recruitment for Ischemic Neovascularization

5. SDF‐1 expression by mesenchymal stem cells results in trophic support of cardiac myocytes after myocardial infarction

Cited by 146 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gene therapy for polygenic or complex diseases;Biomarker Research;2024-09-04

2. Bioderived Nanoparticles for Cardiac Repair;ACS Nano;2024-08-26

3. Elucidating the role of chemokines in inflammaging associated atherosclerotic cardiovascular diseases;Mechanisms of Ageing and Development;2024-08

4. Inhalable cardiac targeting peptide modified nanomedicine prevents pressure overload heart failure in male mice;Nature Communications;2024-07-18

5. Targeting immune cell recruitment in atherosclerosis;Nature Reviews Cardiology;2024-04-25